Strive stock performance snapshot after recent moves

Strive (ASST) has drawn fresh attention after recent trading moves, with the stock last closing at $21.50. Its one-month performance is 76.37%, while the past 3 months show a 20.79% gain.

That recent surge puts Strive’s short term share price momentum firmly in positive territory, although the 1 year total shareholder return is down 81.81% and the 3 year total shareholder return is down 69.72%, so the longer term picture remains challenging.

Compare Strive's sharp rebound with other companies showing strong recent momentum and solid fundamentals by exploring our curated list of 51 high quality undervalued stocks.

After a move like Strive’s, the upside case can look tempting while past losses still weigh heavily. Does the current share price fairly reflect that balance of risk and potential reward, or has it already done most of the work?

Price to book ratio for Strive stock: is 2.8x justified?

On traditional valuation metrics, Strive currently trades on a P/B ratio of 2.8x. That sits at the same level as the wider US Medical Equipment industry average of 2.8x, but below the peer group average of 9.1x.

The P/B ratio compares Strive's market value to its book value, which is the accounting value of its net assets. For asset managers and related financial companies, this metric can help investors frame how much they are paying for each dollar of equity on the balance sheet, especially when earnings are not yet positive.

Strive is currently unprofitable and reports a negative return on equity of 69.07%, so the P/B multiple is not being supported by current earnings. At the same time, the stock's P/B level is well below the peer group average of 9.1x. This suggests investors are paying less per dollar of equity than they are for many similar sized companies, even though Strive is forecast to grow revenue at 14.62% per year and faster than the broader US market.

Compared with the Medical Equipment industry as a whole, Strive's 2.8x P/B aligns closely with the sector norm, while the discount to the 9.1x peer average is substantial. That combination points to a valuation that is in line with the broader industry but materially lower than closer peers on a balance sheet basis.

Result: Price-to-book of 2.8x (ABOUT RIGHT)

However, Strive still carries clear risks, including continued losses of $975.456 million on $8.501 million in revenue and a sharp 81.81% one-year decline in shareholder return.

Next Steps

With Strive facing both steep past losses and recent positive momentum, it makes sense to move quickly, review the underlying data and reach your own judgment with the help of the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Strive?

If Strive has caught your attention, do not stop there. Broaden your watchlist with other stock ideas that fit different risk, income, and balance sheet profiles.

• Identify potential mispricing by scanning companies that combine strong fundamentals with appealing value through the 51 high quality undervalued stocks.
• Strengthen your income focus by checking companies that feature robust payouts using the 11 dividend fortresses.
• Prioritise resilience by reviewing companies highlighted in the 75 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.